Unknown

Dataset Information

0

De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity.

ABSTRACT: Here we report de novo non-synonymous single-nucleotide variants (SNVs) by conducting whole exome sequencing of 18 trios consisting of Japanese patients with sporadic schizophrenia and their parents. Among nine SNVs, we explored the functional impact of the de novo mutation in TBL1XR1 [c.30?C?>?G (p.Phe10Leu)], a gene previously found to be associated with autism spectrum disorder and epilepsy. Protein structural analysis revealed that Phe10Leu mutation may decrease the structural stability of the TBL1XR1 protein. We demonstrate that Phe10Leu mutation alters the interaction of TBL1XR1 with N-CoR and ?-catenin, which play critical roles in regulation of Wnt-mediated transcriptional activity. Consistently, TBL1XR1-mediated activation of Wnt signaling was up-regulated by Phe10Leu mutation. These results suggest that a de novo TBL1XR1 point mutation could alter Wnt/?-catenin signaling activity. Further studies are required to clarify the involvement of TBL1XR1 mutations in neuropsychiatric conditions.

SUBMITTER: Nishi A 

PROVIDER: S-EPMC5460159 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Here we report de novo non-synonymous single-nucleotide variants (SNVs) by conducting whole exome sequencing of 18 trios consisting of Japanese patients with sporadic schizophrenia and their parents. Among nine SNVs, we explored the functional impact of the de novo mutation in TBL1XR1 [c.30 C > G (p.Phe10Leu)], a gene previously found to be associated with autism spectrum disorder and epilepsy. Protein structural analysis revealed that Phe10Leu mutation may decrease the structural stability of t  ...[more]

Similar Datasets

Unknown De novo mutations in inhibitors of Wnt, BMP, and Ras/ERK signaling pathways in non-syndromic midline craniosynostosis.
| S-EPMC5584457 | biostudies-literature
Unknown De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy.
| S-EPMC4947566 | biostudies-literature
Unknown A De Novo Mutation in the Sodium-Activated Potassium Channel KCNT2 Alters Ion Selectivity and Causes Epileptic Encephalopathy.
| S-EPMC5687820 | biostudies-literature
Unknown Novel variation and de novo mutation rates in population-wide de novo assembled Danish trios.
| S-EPMC4309431 | biostudies-literature
Unknown Rare DEGS1 variant significantly alters de novo ceramide synthesis pathway.
| S-EPMC6718439 | biostudies-literature
Unknown De novo MYH9 mutation in congenital scalp hemangioma.
| S-EPMC6071566 | biostudies-literature
Unknown A specific mutation in TBL1XR1 causes Pierpont syndrome.
| S-EPMC4853543 | biostudies-literature
Unknown Single synonymous mutation in factor IX alters protein properties and underlies haemophilia B.
| S-EPMC6192418 | biostudies-literature
Unknown A novel de novo HDAC8 missense mutation causing Cornelia de Lange syndrome.
| S-EPMC8457687 | biostudies-literature
Unknown Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing.
| S-EPMC5110068 | biostudies-literature